During the past decade, Hospital Geral de Santo Antonio conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Geral de Santo Antonio" #1 sponsor was "Bayer" with 3 trials, followed by "Celgene" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Geral de Santo Antonio" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Dutch Heart Foundation" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Geral de Santo Antonio" are "Hepatitis B, Chronic" (2 trials), "Multiple Myeloma" (2 trials), "Rheumatoid Arthritis" (2 trials), "Ulcerative Colitis" (2 trials) and "Acute Stroke" (1 trials). Many other conditions were trialed in "Hospital Geral de Santo Antonio" in a lesser frequency.

Most popular intervention types in "Hospital Geral de Santo Antonio" are "Drug" (26 trials), "Device" (7 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Abemaciclib" (1 trials), "Active Sphenopalatine Ganglion (SPG) Stimulation" (1 trials), "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials) and "Asacol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Geral de Santo Antonio" are 35 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Geral de Santo Antonio". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Hospital Geral de Santo Antonio, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Geral de Santo Antonio, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".